TCL Archive NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions. March 12, 2010
TCL Archive In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI February 6, 1976
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
